Also found in: Medical, Encyclopedia.


(used with a sing. verb) The study of the properties of pharmaceutical preparations and their effects after administration.
References in periodicals archive ?
com)-- SMi Group has announced that Pavel Farkas, Senior Director for Biopharmaceutics Clinical Development at PLIVA, will be joining the speaker line-up for the 15th annual Controlled Release Delivery conference in London next March.
Spireas is the inventor and author of more than 80 international and domestic patents and 200 scientific papers, books and other publications in the fields of industrial pharmacy, biopharmaceutics, pharmacokinetics, pharmaceutical technology and analytical chemistry.
The methods were presented by Prince Bawuah, MSc, in his doctoral dissertation, and the findings were originally published in the International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and Optical Review.
The implementation of in vitro methodologies as alternatives to clinical BE studies has been facilitated by progressive regulatory guidelines such as the Biopharmaceutics Classification System (BCS) and could benefit from the inclusion of innovative technical approaches, such as the in vitro dissolution absorption systems (IDAS) discussed below.
Topic(s):IMI-JU-04-2011-04 - In Vivo Predictive Biopharmaceutics Tools For Oral Drug Delivery
Many of the new drug compounds emanating from drug discovery pipelines are poorly water-soluble, as defined by the Biopharmaceutics Classification System.
Typical fields of application include process development for the production of biopharmaceutics, vaccines, biofuels and secondary metabolites, the optimization of batch, fed-batch, continuous and perfusion processes, as well as scale-up and scale-down experiments.
The amalgamation results in materially enhanced combined service offerings in the strategic segments Chiltern Oncology, Chiltern Biopharmaceutics and Chiltern Source, which specialises in tailored resourcing solutions across clinical, regulatory, medical and biometrics, the buyer noted.
Singh, "Lipid--an emerging platform for oral delivery of drugs with poor bioavailability," European Journal of Pharmaceutics and Biopharmaceutics, vol.
In addition, nadolol is classified as a class III drug in BCS and also Biopharmaceutics Drug Disposition Classification System (BDDCS), characterized by high solubility, low permeability and poor metabolism (Wu and Benet 2005; Yang et al.
This book is intended to provide a summary of the therapeutics as well as other basic pharmaceutical principles (dosage forms, math, biopharmaceutics, kinetics, and basic and parenteral compounding, among others) that will be valuable in preparing for the NAPLEX and also be a resource as one enters practice.
Historical perspectives: A century of dissolution research: From Noyes and Whitney to the biopharmaceutics classification system.